20468 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN, ESTROGEN AND VITAMIN D COMPOUND
#1202COMPOSITION CONTAINING PROGESTIN, PHYTOESTROGEN AND VITAMIN D
#1203ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1204PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3BETA, 17BETA-DIOL
#1205PHARMACEUTICAL COMPOSITION COMPRISING PROGESTOGENS AND/OR ESTROGENS AND 5-METHYL-(6S)-TETRAHYDROFOLATE
#1206Medicaments and methods for wound healing
#1207Diindolylmethane for the treatment of HPV infection
#1208Methods for treating neural cell swelling
#1209Method for treating a disease, disorder or adverse effect caused by an elevated serum concentration of an UGT1A1 substrate
#1210Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#1211Intraocular drug delivery systems
#1212Use of estradiol valerate or 17β-estradiol in combination with dienogest for oral therapy to maintain and/or increase feminine libido
#1213METHODS FOR TREATING POSTMENOPAUSAL WOMEN USING ULTRA-LOW DOSES OF ESTROGEN
#1214X-ray visible drug delivery device
#1215NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1216Trace elements
#1217METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#1218Compounds
#1219Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
#1220Formulations
#1221NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#1222Pharmaceutical Compositions
#1223PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF PRODUCTS THAT INDUCE BIOLOGICAL EFFECTS IN THE OVARIAN EPITHELIUM
#1224AEROSOL FORMULATION FOR THE INHALATION OF BETA AGONISTS
#1225Pharmaceutical composition containing a tetrahydrofolic acid
#1226Delivery system
#1227METHOD FOR MODULATING THE PHARMACOKINETICS AND METABOLISM OF A THERAPEUTIC AGENT
#1228Method and Composition for Treatment of Cutaneous Lesions
#1229Methods of treating hot flashes with formulations for transdermal or transmucosal application
#1230Pharmaceutical compositions
#1231EXTENDED STEP-DOWN ESTROGEN REGIMEN
#1232ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1233METHODS AND COMPOSITIONS FOR TREATING ERECTILE DYSFUNCTION
#1234ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
#1235Formulation for hair growth
#1236Film-shaped drug forms for use in the oral cavity (wafers)
#1237Uses of Erss Modulators
#1238METHODS AND COMPOSITIONS FOR TREATING TRAUMA-HEMORRHAGE USING ESTROGEN AND DERIVATIVES THEREOF
#1239Contraception method
#1240SALT SENSITIVITY AND PREVENTION OF HYPERTENSION WITH DROSPIRENONE
#1241Composition containing Vitamin D and phytoestrogens
#1242Transdermal pharmaceutical composition
#1243Mucosal formulation
#1244Combination Product Comprising Src Kinase Inhibitor Azdo530 and an Antioestrogen or Egfr-Tk-Inhibitor
#1245Treatment of menopause associated symptoms
#1246Film-Shaped Medicament for Oral Administration Containing Estriol
#1247METHODS FOR PREVENTION AND TREATMENT OF CONDITIONS ARISING FROM LOCAL ESTROGEN DEFICIENCY
#1248Pharmaceutical compositions comprising trimegestone
#1249PREVENTION OF OVARIAN CANCER BY ADMINISTRATION OF AGENTS THAT INDUCE BIOLOGIC RESPONSES
#1250Extended cycle multiphasic oral contraceptive method
#1251Emulsion-based microparticles and methods for the production thereof
#1252Muc1 Antagonist Enhancement of Death Receptor Ligand-Induced Apoptosis
#1253Combination therapy using anti-EGFR antibodies and anti-hormonal agents
#1254Methods and devices for the sustained release of multiple drugs
#1255Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen
#1256Method for the production of emulsion-based microparticles
#1257Administration of non-oral androgenic steroids to women
#1258OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES
#1259Use of sex steroid function modulators to treat wounds and fibrotic disorders
#1260Method for measuring aromatase activity
#1261POLYCYCLIC PHENOLIC COMPOUNDS AND USE IN TREATING VIRAL INFECTIONS
#1262Delayed release carnitine
#1263Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same
#1264PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
#1265Separation of fulvestrant isomers
#12662-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
#1267Local Deliver of 17-Beta Estradiol for Preventing Vascular Intimal Hyperplasia and for Improving Vascular Endothelium Function after Vascular Injury
#1268Drug delivery system based on polyethylene vinylacetate copolymers
#12692-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
#12702-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole and estrogen formulations
#1271Combination therapy for the treatment of cancer
#1272Method of preventive on-demand hormonal contraception
#1273Compositions of estrogen-cyclodextrin complexes
#1274Exemestane compounds, compositions and related methods of use
#1275Method of treating or preventing type-2 diabetes
#1276Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest
#1277Therapeutic composition for the treatment of dry eye syndrome
#1278Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
#1279Oil emulsion for postnatal hormone substitution
#1280Transdermal hormone delivery system: compositions and methods
#1281External patch containing estrogen and/or progestogen
#1282Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
#1283Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#1284Combination therapy of peptide vaccination and estramustine treatment
#1285Methods and compositions using gonadotropin hormone releasing hormone
#1286Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
#1287Estrogen compositions and therapeutic methods of use thereof
#1288Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#1289Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#1290Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#1291Oral contraception with trimegestone
#1292Cyclodextrin nanotechnology for ophthalmic drug delivery
#1293Methods and reagents for the treatment of immunoinflammatory disorders
#1294Prevention of ovarian cancer by administration of a vitamin D compound
#1295Compositions and methods for treatment of cycle-related symptoms
#1296Estrogen compositions for vaginal administration
#1297Estrogen compositions for vaginal administration
#1298Anti-angiogenic compositions and methods of use
#1299Anti-angiogenic compositions and methods of use
#1300Formulations of conjugated estrogens and bazedoxifene
#1301Medicaments
#1302Method for treatment and chemoprevention of prostate cancer
#1303HRT formulations
#1304Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
#1305Tanaproget compositions containing ethinyl estradiol
#1306Drug delivery system
#1307Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
#1308Methods for treating brain swelling with a compound that blocks a non-selective cation channel
#130916-Hydroxyestratrienes as selectively active estrogens
#1310Method and apparatus for transdermal or transmucosal application of testosterone
#1311Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
#1312Stability of progestogen formulations
#1313Carrier
#1314Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
#1315Multi-layered transdermal system with triazine UV absorber
#1316Extended estrogen dosing contraceptive regimen
#1317Anti-angiogenic compositions and methods of use
#1318Modulation of neurodegenerative diseases through the estrogen receptor
#1319Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates
#13202-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
#1321Method for treating erectile dysfunction and increasing libido in men
#1322Low dose estrogen interrupted hormone replacement therapy
#1323Combination therapy for topical application in the treatment of dry eye syndrome
#1324Methods useful in the treatment of bone resorption diseases
#1325Pharmaceutically acceptable carrier for ophthalmic compositions
#1326Modulation of neurodegenerative diseases through the progesterone receptor
#1327Solid peroral contraceptive preparations
#1328Device for delivery of TRPV1 agonists
#1329Estradiol metabolites for the treatment of pulmonary hypertension
#1330Transdermal systems having control delivery system
#1331Devices for delivering agents to a vaginal tract
#1332Estrogenic compounds as anti-mitotic agents
#1333Compositions of unconjugated estrogens and methods for their use
#1334Device having hydration inhibitor
#1335Encapsulated or coated stent systems
#13362-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action
#1337Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
#1338Surgical implant comprising an anabolic and a corticosteroid
#1339Estrogen replacement therapy
#1340Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
#1341Ophthalmic compositions comprising Aloe Vera
#1342Method for treatment of dysmenorrhea
#1343Anti-angiogenic compositions and methods of use
#1344Combination of organic compounds
#1345Methods for treating or preventing cancer by preventing, inhibiting, or arresting cell cycling
#1346Pharmaceutical application of 15- or 16-substituted testosterone analogues
#1347Anti-angiogenic compositions and methods of use
#1348Cyclic peptide compositions for treatment of sexual dysfunction
#1349Methods for treating spinal cord injury with a compound that inhibits a NCchannel
#1350Pharmaceutical compositions for the treatment of urinary incontinence
#1351Composition containing an androgenous 11b-halogen steroid and a progestational hormone, and male contraceptive based on said composition
#1352Hydroxide-releasing agents as skin permeation enhancers
#1353Dosage form for hormonal contraception
#1354Estrogen replacement regimen
#1355Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion
#1356Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#1357Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same
#1358Controlled release compositions of estradiol metabolites
#1359Estrogenic compounds as anti-mitotic agents
#1360Device for transdermal administration of drugs including acrylic polymers
#1361Tetrol steroids and esters
#1362Pharmaceutical composition comprising estetrol derivatives for use in cancer therapy
#1363Calcilytic compounds
#1364Treatment of lung diseases and pre-lung disease conditions
#1365Hormone replacement therapy
#1366Delayed release carnitine
#1367MODIFIED, HYDROXY-SUBSTITUTED AROMATIC STRUCTURES HAVING CYTOPROTECTIVE ACTIVITY
#1368Nasal spray formulation and method
#1369Topical compositions for anti-aging and methods of using same
#1370Therapy for andropause using estrogen agonists/antagonists and testosterone
#1371Dosage Regimen and Pharmaceutical Composition for Emergency Contraception
#1372Pharmaceutical compositions and treatment methods-7
#1373Treatment of aromatase inhibitor therapy-related osteoporosis
#1374Compositions and methods for treatment of premenstrual dysphoric disorder
#1375Sugar coatings and methods therefor
#1376Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate
#1377Dosage form for hormonal contraception
#1378Hormonal contraceptive containing a combination of ethinyloestradiol and chlormadinone acetate
#1379Use of a combination of ethinyloestradiol and chlormadinone acetate to produce a pharmaceutical preparation
#1380Method of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
#1381Asthma and colitis treatment methods
#1382Methods for treating postmenopausal women using ultra-low doses of estrogen
#1383Management of breakthrough bleeding in extended hormonal contraceptive regimens
#1384Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
#1385Estriol therapy for multiple sclerosis and other autoimmune diseases
#1386Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
#1387Extended cycle multiphasic oral contraceptive method
#1388Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology
#1389Method of treating human skin and a skin care composition for use in such a method
#1390Sequential SPRM/progestin treatment
#1391Use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune disorders
#1392Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery
#1393Anti-angiogenic compositions and methods of use
#1394Stabilised supersaturated solids of lipophilic drugs
#1395Transdermal systems containing multilayer adhesive matrices to modify drug delivery
#1396Methods and reagents for the treatment of inflammatory disorders
#1397Compositions of estrogen-cyclodextrin complexes
#1398Methods for treating neural cell swelling
#1399Progestagenic dosage unit
#1400Composition and method for treatment and chemoprevention of prostate cancer
#1401Menstrual cycle control and improvement of conception rates in females
#1402Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
#1403Growth promoting pharmaceutical implant
#1404Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12
#1405Pharmaceutical compositions and treatment methods - 8
#1406Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
#1407Method of increasing testosterone and related steroid concentrations in women
#1408Prevention and treatment of hypertensive heart diseases by the selective estrogens 8beta-vinyl-estra-1,3,5(10)-trien-3,17beta-diol and 17beta-fluor-9alpha-vinyl-estra-1,3,5(10)-trien-3,16alpha-diol
#1409Pharmaceutical composition and method for treating hypogonadism
#1410Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#1411Oil or fat composition
#1412Anti-angiogenic compositions and methods of use
#1413Method of treating breast cancer
#1414Methods and reagents for the treatment of immunoinflammatory disorders
#1415Composition
#1416Androgen pharmaceutical composition and method for treating depression
#1417Pharmaceutical composition and method for treating hypogonadism
#1418Therapeutic regimens for administering drug combinations
#1419Pharmaceutical composition and method for treating hypogonadism
#1420Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
#1421Graduated estrogen contraceptive
#1422Novel testosterone ester formulation for human use
#1423Treatment of osteoporosis
#1424Extended triphasic contraceptive regimens
#1425Methods of preventing or treating disorders by administering and integrin alphanubeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
#1426Methods of inhibiting osteoclast activity
#1427Neurological disorder treatment methods
#1428Estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
#1429Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
#1430Combination contraceptive, kits that contain the latter, and a method that uses the latter
#1431Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and an estrogen
#1432Combination of organic compounds
#1433Norethindrone sustained release formulations and methods associated therewith
#1434Modified, hydroxy-substituted aromatic structures having cytoprotective activity
#1435Method for treating erectile dysfunction and increasing libido in men
#1436Method for treating erectile dysfunction and increasing libido in men
#1437Treatment method
#1438Formulation
#1439Pharmaceutical composition and method for transdermal drug delivery
#1440Triphasic oral contraceptive
#1441Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
#1442Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
#1443Antitumor combined therapy
#1444Hormone replacement therapy and depression
#1445Dosage regimen and pharmaceutical composition for emergency contraception
#1446Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy
#1447Contraception method using competitive progesterone antagonists and novel compounds useful therein
#1448Method and compositions for increasing bone mass
#1449Pharmaceutical formulation for contraception and hormone-replacement therapy
#1450Estrogenic compounds as anti-mitotic agents
#1451Pharmaceutical composition and method for transdermal drug delivery
#1452Enhancement of activity and/or duration of action of selected anti-inflammatory steroids for topical or other local application
#1453Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
#1454Hormonal contraceptive product
#1455Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
#1456Method and system for tuning hormone receptors through the dynamic intravenous delivery of a hormone according to a target physiological cadence
#1457Adapter for use in a planetary mixer
#1458Method of providing birth control
#1459Composition and method to aid in hormone replacement therapy
#1460Isolation and purification of conjugated estrogens
#1461Treatment and inhibition of protozoal diseases with nandrolone and its derivatives